ClinicalTrials.Veeva

Menu

Pentraxin-3 in Chronic Renal Failure

H

Haseki Training and Research Hospital

Status

Completed

Conditions

Chronic Kidney Disease
Inflammation

Study type

Observational

Funder types

Other

Identifiers

NCT01397773
PTX-HASEKI

Details and patient eligibility

About

The aim of the study is to measure Pentraxin-3 levels in patients on hemodialysis, peritoneal dialysis and those in the pre-dialysis period; and to compare these groups with the control group; so as to investigate the eligibility of it as a reliable marker of inflammation; relationship with other inflammatory markers and carotis intima media thickness.

Full description

The investigators planned to involve four group of patients: Hemodialysis, peritoneal dialysis, pre-dialysis and the control group; with about 25 patients planned to be involved in each group. The laboratory parameters to be measured are Pentraxin-3, C-reactive protein (CRP), high sensitive CRP, fibrinogen and interleukin-6. Concomitantly, carotis intima media thickness will be measured in the radiology clinic. Statistical analysis will be carried on by Statistical Package for Social Sciences (SPSS) for Windows 13.0. The variables acting on the inflammatory parameters and the correlation between them and carotis intima media thickness will be studied.

Enrollment

85 estimated patients

Sex

All

Ages

16 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • To give informed consent
  • Hemodialysis or peritoneal dialysis for more than 3 months
  • Creatinin clearance less than 30 ml/min for the pre-dialysis group

Exclusion criteria

  • Not to give informed concent
  • Active infection within the last 3 months
  • Known chronic inflammatory disease

Trial design

85 participants in 4 patient groups

Hemodialysis group
Description:
Patients on chronic hemodialysis program
Peritoneal dialysis group
Description:
Patients on chronic peritoneal dialysis program
Pre-dialysis group
Description:
Patients with chronic kidney disease stage-4
Control group
Description:
Healthy subjects

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems